www.dailypolitical.com ·
Varex Imaging Nasdaqvrex Releases Earnings Results Misses Estimates by 0 01 Eps
Topic context
This topic has been covered 367759 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedVarex Imaging (VREX) reported a slight earnings miss and revenue in line with estimates, with weak Q3 guidance. The company is a medical imaging component supplier. Commercial mechanism is weak: the miss is small and the guidance range is wide, indicating uncertainty but no clear supply/demand shock. Debt refinancing improves balance sheet but does not directly affect product prices or margins. No scarcity or supply chain disruption identified.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Varex Imaging Q2 2026 EPS $0.21 vs estimate $0.22, miss by $0.01
- Q2 revenue $216M vs forecast $216.92M
- Q3 2026 guidance EPS $0.150-$0.300
- Debt refinancing completed, debt reduced to ~$263M
- Stock down $0.34 to $11.83, market cap $495.68M
Related stories
finance.yahoo.com
Ncmi Q1 2026 Earnings Transcript
finance.yahoo.com
Transcript Valneva Q1 2026 Earnings
fool.com
Keysight Keys Q2 2026 Earnings Transcript
economictimes.indiatimes.com
The Rs 3 Relief That Wasnt Why Investors Are Dumping Oil Stocks After Long Awaited Petrol Diesel Price Hike
livemint.com